Gender Differences and Their Effects on Survival Outcomes in Lung Cancer Patients Treated With PD-1/PD-L1 Checkpoint Inhibitors: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Gender Differences and Their Effects on Survival Outcomes in Lung Cancer Patients Treated With PD-1/PD-L1 Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Published:2022-12 Issue:12 Volume:34 Page:799-809
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Madala S.,Rasul R.,Singla K.,Sison C.P.,Seetharamu N.,Castellanos M.R.

Funder

New York State Department of Health

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference39 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

2. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front Pharmacol,2017

3. PD-1/PD-L1 inhibitors;Sunshine;Curr Opin Pharmacol,2015

4. Estrogen receptors regulate innate immune cells and signaling pathways;Kovats;Cell Immunol,2015

5. Sex differences in immune responses;Klein;Nat Rev Immunol,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer;Translational Research;2024-10

2. Non–Small Cell Lung Cancer Metastatic Without Oncogenic Alterations;American Society of Clinical Oncology Educational Book;2024-06

3. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

4. Lung cancer in females—sex-based differences from males in epidemiology, biology, and outcomes: a narrative review;Translational Lung Cancer Research;2024-01

5. Let's Talk About Sex: Survival Among Females and Males in a Real-World Cohort Treated with Pembrolizumab for Non-Small Cell Lung Cancer;2024